Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers [NA]
This clinical trial update describes a study evaluating early salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers to assess…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months [Phase 1, Phase 2]
Phase 1/2 trial evaluating AsiDNA, a DNA repair inhibitor, in combination with PARP inhibitors for relapsed platinum-sensitive ovarian cance…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer [Phase 1, Phase 2]
This entry notes a Phase 1/Phase 2 clinical trial combining fuzuloparib with arsenic trioxide for platinum-resistant relapsed ovarian cancer…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer
This is a prospective multicenter diagnostic biomarker study designed to discriminate borderline ovarian tumors from stage I invasive ovaria…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC [Phase 2]
Phase 2 trial assessing OSE2101 alone or in combination with pembrolizumab versus best supportive care in patients with platinum-sensitive o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer [Phase 2]
A Phase 2 trial is evaluating pamiparib combined with surufatinib as neoadjuvant therapy for unresectable ovarian cancer. The study is curre…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of surufatinib combined with carboplatin/paclitaxel and with olaparib as first-line and…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Fluzoparib Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 clinical trial update shows fluzoparib as neoadjuvant therapy for ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Establishment and Clinical Application of AI-based Multimodal Diagnosis System for Ovarian Tumors [NA]
A trial update reports the establishment and clinical application of an AI-based multimodal diagnostic system for ovarian tumors, with the s…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer [NA]
This clinical trial is evaluating sentinel lymph node biopsy for early-stage ovarian cancer and is currently recruiting at Istanbul Universi…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: FPA150 in Patients With Advanced Solid Tumors [EARLY_Phase 1]
This early-phase 1 trial of FPA150 in breast cancer, ovarian cancer, and endometrial cancer has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) [Phase 1]
This document reports the completion status of a Phase 1 clinical trial of IMAB027 in patients with recurrent advanced ovarian cancer.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
This clinical trial update outlines an ongoing audit of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) sponsor…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
This clinical trial update reports completion of a study investigating homologous recombination in ovarian cancers, including ovarian cancer…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
This clinical trials registry entry reports the development and validation of a prediction model for acute kidney injury after cisplatin-bas…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) [Phase 1, Phase 2]
Astellas-sponsored study evaluating intermittent and continuous OSI-906 with weekly paclitaxel in recurrent ovarian cancer and other solid t…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: High Definition Profiling of Ovarian Cancer Ascites
Update on a clinical trial evaluating high-definition profiling of ovarian cancer ascites; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers [Phase 1, Phase 2]
Clinical trial update for Galinpepimut-S in combination with pembrolizumab in selected advanced cancers (Phase 1/2) with completed status an…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of an immunostimulatory oncolytic adenovirus has completed with posted results across pancreatic adenocarcinoma, ovarian c…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: HOT: HIPEC in Ovarian Cancer as Initial Treatment [Phase 2]
Phase 2 trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) as initial treatment for Stage III/IV ovarian cancer is currently…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age
A pediatric ovarian tissue banking trial is currently recruiting females aged 0-18, collecting operative specimens for conditions including …
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients [Phase 3]
Phase 3 trial update evaluating maintenance therapy with rucaparib after bevacizumab maintenance following carboplatin-based first-line chem…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue [NA]
The REVITALIZE trial evaluating a telehealth intervention for women with advanced ovarian cancer and PARP-inhibitor–related fatigue has comp…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
This document provides an update on a Phase 1 trial evaluating autologous CAR T cells in patients with advanced, platinum-resistant ovarian,…